Fisher Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $759M | Sell |
|
|||||
|
2025
Q1 | $824M | Sell |
|
|||||
|
2024
Q4 | $1.09B | Sell |
|
|||||
|
2024
Q3 | $1.58B | Sell |
|
|||||
|
2024
Q2 | $1.91B | Sell |
|
|||||
|
2024
Q1 | $1.76B | Sell |
|
|||||
|
2023
Q4 | $1.46B | Sell |
|
|||||
|
2023
Q3 | $1.34B | Sell |
|
|||||
|
2023
Q2 | $1.23B | Sell |
|
|||||
|
2023
Q1 | $1.25B | Sell |
|
|||||
|
2022
Q4 | $1.22B | Sell |
|
|||||
|
2022
Q3 | $930M | Sell |
|
|||||
|
2022
Q2 | $1.6B | Sell |
|
|||||
|
2022
Q1 | $1.77B | Sell |
|
|||||
|
2021
Q4 | $1.79B | Sell |
|
|||||
|
2021
Q3 | $1.55B | Buy |
|
|||||
|
2021
Q2 | $1.35B | Buy |
|
|||||
|
2021
Q1 | $1.08B | Buy |
|
|||||
|
2020
Q4 | $1.11B | Buy |
|
|||||
|
2020
Q3 | $1.09B | Buy |
|
|||||
|
2020
Q2 | $1.01B | Buy |
|
|||||
|
2020
Q1 | $923M | Buy |
|
|||||
|
2019
Q4 | $873M | Sell |
|
|||||
|
2019
Q3 | $786M | Buy |
|
|||||
|
2019
Q2 | $761M | Buy |
|
|||||
|
2019
Q1 | $763M | Buy |
|
|||||
|
2018
Q4 | $654M | Buy |
|
|||||
|
2018
Q3 | $650M | Buy |
|
|||||
|
2018
Q2 | $626M | Buy |
|
|||||
|
2018
Q1 | $647M | Buy |
|
|||||
|
2017
Q4 | $682M | Buy |
|
|||||
|
2017
Q3 | $584M | Buy |
|
|||||
|
2017
Q2 | $501M | Buy |
|
|||||
|
2017
Q1 | $355M | Sell |
|
|||||
|
2016
Q4 | $381M | Sell |
|
|||||
|
2016
Q3 | $454M | Sell |
|
|||||
|
2016
Q2 | $607M | Sell |
|
|||||
|
2016
Q1 | $627M | Sell |
|
|||||
|
2015
Q4 | $665M | Sell |
|
|||||
|
2015
Q3 | $632M | Sell |
|
|||||
|
2015
Q2 | $673M | Sell |
|
|||||
|
2015
Q1 | $676M | Sell |
|
|||||
|
2014
Q4 | $552M | Sell |
|
|||||
|
2014
Q3 | $637M | Sell |
|
|||||
|
2014
Q2 | $635M | Buy |
|
|||||
|
2014
Q1 | $622M | Buy |
|
|||||
|
2013
Q4 | $500M | Buy |
|
|||||
|
2013
Q3 | $457M | Buy |
|
|||||
|
2013
Q2 | $417M | Buy |
|